English
简体中文
Total: £ 56.28
Published Date: 2024-06-18 | Pages: 85 | Tables: 188 | Pharma & Healthcare
Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.
The global Tagrisso (Osimertinib) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tagrisso (Osimertinib) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tagrisso (Osimertinib) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tagrisso (Osimertinib), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tagrisso (Osimertinib).
Report Scope
The Tagrisso (Osimertinib) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tagrisso (Osimertinib) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tagrisso (Osimertinib) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Incepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
Segment by Type
40 mg
80 mg
Segment by Application
Locally Advanced NSCLC
Metastatic NSCLC
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tagrisso (Osimertinib) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tagrisso (Osimertinib) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Tagrisso (Osimertinib) Market Overview
1.1 Product Overview and Scope of Tagrisso (Osimertinib)
1.2 Tagrisso (Osimertinib) Segment by Type
1.2.1 Global Tagrisso (Osimertinib) Market Value Comparison by Type (2024-2030)
1.2.2 40 mg
1.2.3 80 mg
1.3 Tagrisso (Osimertinib) Segment by Application
1.3.1 Global Tagrisso (Osimertinib) Market Value by Application: (2024-2030)
1.3.2 Locally Advanced NSCLC
1.3.3 Metastatic NSCLC
1.3.4 Other
1.4 Global Tagrisso (Osimertinib) Market Size Estimates and Forecasts
1.4.1 Global Tagrisso (Osimertinib) Revenue 2019-2030
1.4.2 Global Tagrisso (Osimertinib) Sales 2019-2030
1.4.3 Global Tagrisso (Osimertinib) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tagrisso (Osimertinib) Market Competition by Manufacturers
2.1 Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2019-2024)
2.4 Global Tagrisso (Osimertinib) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tagrisso (Osimertinib), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tagrisso (Osimertinib), Product Type & Application
2.7 Tagrisso (Osimertinib) Market Competitive Situation and Trends
2.7.1 Tagrisso (Osimertinib) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue
2.7.3 Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tagrisso (Osimertinib) Retrospective Market Scenario by Region
3.1 Global Tagrisso (Osimertinib) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tagrisso (Osimertinib) Global Tagrisso (Osimertinib) Sales by Region: 2019-2030
3.2.1 Global Tagrisso (Osimertinib) Sales by Region: 2019-2024
3.2.2 Global Tagrisso (Osimertinib) Sales by Region: 2025-2030
3.3 Global Tagrisso (Osimertinib) Global Tagrisso (Osimertinib) Revenue by Region: 2019-2030
3.3.1 Global Tagrisso (Osimertinib) Revenue by Region: 2019-2024
3.3.2 Global Tagrisso (Osimertinib) Revenue by Region: 2025-2030
3.4 North America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.4.1 North America Tagrisso (Osimertinib) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tagrisso (Osimertinib) Sales by Country (2019-2030)
3.4.3 North America Tagrisso (Osimertinib) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tagrisso (Osimertinib) Market Facts & Figures by Country
3.5.1 Europe Tagrisso (Osimertinib) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tagrisso (Osimertinib) Sales by Country (2019-2030)
3.5.3 Europe Tagrisso (Osimertinib) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tagrisso (Osimertinib) Market Facts & Figures by Country
3.6.1 Asia Pacific Tagrisso (Osimertinib) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tagrisso (Osimertinib) Sales by Country (2019-2030)
3.6.3 Asia Pacific Tagrisso (Osimertinib) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.7.1 Latin America Tagrisso (Osimertinib) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tagrisso (Osimertinib) Sales by Country (2019-2030)
3.7.3 Latin America Tagrisso (Osimertinib) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tagrisso (Osimertinib) Market Facts & Figures by Country
3.8.1 Middle East and Africa Tagrisso (Osimertinib) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tagrisso (Osimertinib) Sales by Type (2019-2030)
4.1.1 Global Tagrisso (Osimertinib) Sales by Type (2019-2024)
4.1.2 Global Tagrisso (Osimertinib) Sales by Type (2025-2030)
4.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Type (2019-2030)
4.2 Global Tagrisso (Osimertinib) Revenue by Type (2019-2030)
4.2.1 Global Tagrisso (Osimertinib) Revenue by Type (2019-2024)
4.2.2 Global Tagrisso (Osimertinib) Revenue by Type (2025-2030)
4.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Type (2019-2030)
4.3 Global Tagrisso (Osimertinib) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tagrisso (Osimertinib) Sales by Application (2019-2030)
5.1.1 Global Tagrisso (Osimertinib) Sales by Application (2019-2024)
5.1.2 Global Tagrisso (Osimertinib) Sales by Application (2025-2030)
5.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Application (2019-2030)
5.2 Global Tagrisso (Osimertinib) Revenue by Application (2019-2030)
5.2.1 Global Tagrisso (Osimertinib) Revenue by Application (2019-2024)
5.2.2 Global Tagrisso (Osimertinib) Revenue by Application (2025-2030)
5.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Application (2019-2030)
5.3 Global Tagrisso (Osimertinib) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Tagrisso (Osimertinib) Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Incepta Pharmaceuticals Ltd
6.2.1 Incepta Pharmaceuticals Ltd Corporation Information
6.2.2 Incepta Pharmaceuticals Ltd Description and Business Overview
6.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Portfolio
6.2.5 Incepta Pharmaceuticals Ltd Recent Developments/Updates
6.3 Lonza AG
6.3.1 Lonza AG Corporation Information
6.3.2 Lonza AG Description and Business Overview
6.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lonza AG Tagrisso (Osimertinib) Product Portfolio
6.3.5 Lonza AG Recent Developments/Updates
6.4 Everest Pharmaceuticals
6.4.1 Everest Pharmaceuticals Corporation Information
6.4.2 Everest Pharmaceuticals Description and Business Overview
6.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Portfolio
6.4.5 Everest Pharmaceuticals Recent Developments/Updates
6.5 Beacon Pharmaceuticals Limited
6.5.1 Beacon Pharmaceuticals Limited Corporation Information
6.5.2 Beacon Pharmaceuticals Limited Description and Business Overview
6.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Portfolio
6.5.5 Beacon Pharmaceuticals Limited Recent Developments/Updates
6.6 Drug International Limited
6.6.1 Drug International Limited Corporation Information
6.6.2 Drug International Limited Description and Business Overview
6.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Drug International Limited Tagrisso (Osimertinib) Product Portfolio
6.6.5 Drug International Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tagrisso (Osimertinib) Industry Chain Analysis
7.2 Tagrisso (Osimertinib) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tagrisso (Osimertinib) Production Mode & Process
7.4 Tagrisso (Osimertinib) Sales and Marketing
7.4.1 Tagrisso (Osimertinib) Sales Channels
7.4.2 Tagrisso (Osimertinib) Distributors
7.5 Tagrisso (Osimertinib) Customers
8 Tagrisso (Osimertinib) Market Dynamics
8.1 Tagrisso (Osimertinib) Industry Trends
8.2 Tagrisso (Osimertinib) Market Drivers
8.3 Tagrisso (Osimertinib) Market Challenges
8.4 Tagrisso (Osimertinib) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tagrisso (Osimertinib) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tagrisso (Osimertinib) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tagrisso (Osimertinib) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tagrisso (Osimertinib) Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tagrisso (Osimertinib) Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tagrisso (Osimertinib), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tagrisso (Osimertinib), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tagrisso (Osimertinib), Product Type & Application
Table 12. Global Key Manufacturers of Tagrisso (Osimertinib), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tagrisso (Osimertinib) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tagrisso (Osimertinib) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tagrisso (Osimertinib) Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Tagrisso (Osimertinib) Sales Market Share by Region (2019-2024)
Table 19. Global Tagrisso (Osimertinib) Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Tagrisso (Osimertinib) Sales Market Share by Region (2025-2030)
Table 21. Global Tagrisso (Osimertinib) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2019-2024)
Table 23. Global Tagrisso (Osimertinib) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2025-2030)
Table 25. North America Tagrisso (Osimertinib) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tagrisso (Osimertinib) Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Tagrisso (Osimertinib) Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Tagrisso (Osimertinib) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tagrisso (Osimertinib) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tagrisso (Osimertinib) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tagrisso (Osimertinib) Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Tagrisso (Osimertinib) Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Tagrisso (Osimertinib) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tagrisso (Osimertinib) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tagrisso (Osimertinib) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tagrisso (Osimertinib) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tagrisso (Osimertinib) Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Tagrisso (Osimertinib) Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Tagrisso (Osimertinib) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tagrisso (Osimertinib) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tagrisso (Osimertinib) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tagrisso (Osimertinib) Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Tagrisso (Osimertinib) Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Tagrisso (Osimertinib) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tagrisso (Osimertinib) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tagrisso (Osimertinib) Sales (K Pcs) by Type (2019-2024)
Table 51. Global Tagrisso (Osimertinib) Sales (K Pcs) by Type (2025-2030)
Table 52. Global Tagrisso (Osimertinib) Sales Market Share by Type (2019-2024)
Table 53. Global Tagrisso (Osimertinib) Sales Market Share by Type (2025-2030)
Table 54. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2019-2024)
Table 57. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2025-2030)
Table 58. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Tagrisso (Osimertinib) Sales (K Pcs) by Application (2019-2024)
Table 61. Global Tagrisso (Osimertinib) Sales (K Pcs) by Application (2025-2030)
Table 62. Global Tagrisso (Osimertinib) Sales Market Share by Application (2019-2024)
Table 63. Global Tagrisso (Osimertinib) Sales Market Share by Application (2025-2030)
Table 64. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2019-2024)
Table 67. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2025-2030)
Table 68. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. AstraZeneca Tagrisso (Osimertinib) Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Incepta Pharmaceuticals Ltd Corporation Information
Table 76. Incepta Pharmaceuticals Ltd Description and Business Overview
Table 77. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product
Table 79. Incepta Pharmaceuticals Ltd Recent Developments/Updates
Table 80. Lonza AG Corporation Information
Table 81. Lonza AG Description and Business Overview
Table 82. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Lonza AG Tagrisso (Osimertinib) Product
Table 84. Lonza AG Recent Developments/Updates
Table 85. Everest Pharmaceuticals Corporation Information
Table 86. Everest Pharmaceuticals Description and Business Overview
Table 87. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Everest Pharmaceuticals Tagrisso (Osimertinib) Product
Table 89. Everest Pharmaceuticals Recent Developments/Updates
Table 90. Beacon Pharmaceuticals Limited Corporation Information
Table 91. Beacon Pharmaceuticals Limited Description and Business Overview
Table 92. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product
Table 94. Beacon Pharmaceuticals Limited Recent Developments/Updates
Table 95. Drug International Limited Corporation Information
Table 96. Drug International Limited Description and Business Overview
Table 97. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Drug International Limited Tagrisso (Osimertinib) Product
Table 99. Drug International Limited Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Tagrisso (Osimertinib) Distributors List
Table 103. Tagrisso (Osimertinib) Customers List
Table 104. Tagrisso (Osimertinib) Market Trends
Table 105. Tagrisso (Osimertinib) Market Drivers
Table 106. Tagrisso (Osimertinib) Market Challenges
Table 107. Tagrisso (Osimertinib) Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tagrisso (Osimertinib)
Figure 2. Global Tagrisso (Osimertinib) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tagrisso (Osimertinib) Market Share by Type in 2023 & 2030
Figure 4. 40 mg Product Picture
Figure 5. 80 mg Product Picture
Figure 6. Global Tagrisso (Osimertinib) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tagrisso (Osimertinib) Market Share by Application in 2023 & 2030
Figure 8. Locally Advanced NSCLC
Figure 9. Metastatic NSCLC
Figure 10. Other
Figure 11. Global Tagrisso (Osimertinib) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tagrisso (Osimertinib) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tagrisso (Osimertinib) Sales (2019-2030) & (K Pcs)
Figure 14. Global Tagrisso (Osimertinib) Average Price (US$/Pcs) & (2019-2030)
Figure 15. Tagrisso (Osimertinib) Report Years Considered
Figure 16. Tagrisso (Osimertinib) Sales Share by Manufacturers in 2023
Figure 17. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Tagrisso (Osimertinib) Players: Market Share by Revenue in 2023
Figure 19. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Tagrisso (Osimertinib) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tagrisso (Osimertinib) Sales Market Share by Country (2019-2030)
Figure 22. North America Tagrisso (Osimertinib) Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tagrisso (Osimertinib) Sales Market Share by Country (2019-2030)
Figure 26. Europe Tagrisso (Osimertinib) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tagrisso (Osimertinib) Revenue Market Share by Region (2019-2030)
Figure 34. China Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Tagrisso (Osimertinib) Sales Market Share by Country (2019-2030)
Figure 45. Latin America Tagrisso (Osimertinib) Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Tagrisso (Osimertinib) Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Tagrisso (Osimertinib) Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Tagrisso (Osimertinib) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Tagrisso (Osimertinib) by Type (2019-2030)
Figure 55. Global Revenue Market Share of Tagrisso (Osimertinib) by Type (2019-2030)
Figure 56. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2019-2030)
Figure 57. Global Sales Market Share of Tagrisso (Osimertinib) by Application (2019-2030)
Figure 58. Global Revenue Market Share of Tagrisso (Osimertinib) by Application (2019-2030)
Figure 59. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2019-2030)
Figure 60. Tagrisso (Osimertinib) Value Chain
Figure 61. Tagrisso (Osimertinib) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
